Literature DB >> 28450682

Clinical Serum Therapy: Benefits, Cautions, and Potential Applications.

Toru Hifumi1, Akihiko Yamamoto2, Manabu Ato3, Kyoko Sawabe4, Kazunori Morokuma5, Nobuya Morine6, Yutaka Kondo7, Eiichiro Noda8, Atsushi Sakai9, Jin Takahashi10, Kazuo Umezawa11.   

Abstract

Blood serum from immunized humans or animals (e.g., horses) contains relevant antibodies and has been used as serum therapy to treat many diseases or envenomation events. The effectiveness of blood serum was initially discovered in 1890 when Kitasato and von Behring observed the effectiveness of this type of therapy against diphtheria and tetanus. Serum therapies played an important role in the advancement of modern medicine prior to the development of penicillin and steroids. At present, several types of serum therapy remain in clinical use. However, some physicians have a limited understanding of the nature and the benefits of serum therapy and the factors that require particular attention. In this review, we set out to clarify the benefits, cautions, and potential applications of serum therapy in the context of conditions such as gas gangrene, diphtheria, botulism, and tetanus and bites from three snake species (mamushi, habu, and yamakagashi) and the redback spider. It is hoped that this review will help clinicians to learn about clinical serum therapies and become familiar with their applications.

Entities:  

Keywords:  antivenom; critical care; envenomation; passive immunization; serum therapy

Mesh:

Substances:

Year:  2017        PMID: 28450682     DOI: 10.2302/kjm.2016-0017-IR

Source DB:  PubMed          Journal:  Keio J Med        ISSN: 0022-9717


  5 in total

Review 1.  Plasma therapy: a passive resistance against the deadliest.

Authors:  Anita Hansda; Debarati Biswas; Aishwarya Bhatta; Nishant Chakravorty; Gayatri Mukherjee
Journal:  Hum Vaccin Immunother       Date:  2021-12-09       Impact factor: 4.526

2.  Clinical characteristics of jellyfish stings in Japan.

Authors:  Toru Hifumi; Yoshimune Fukuchi; Norio Otani; Yutaka Kondo; Takeshi Kitamoto; Kentaro Kobayashi; Nobuaki Nakaya; Joji Tomioka
Journal:  Acute Med Surg       Date:  2019-11-25

3.  Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19.

Authors:  Changzhong Jin; Bin Yu; Jie Zhang; Hao Wu; Xipeng Zhou; Hangping Yao; Fumin Liu; Xiangyun Lu; Linfang Cheng; Miao Jiang; Nanping Wu
Journal:  BMC Infect Dis       Date:  2021-04-16       Impact factor: 3.090

4.  Rhabdophis tigrinus (Yamakagashi) Bites in Japan Over the Last 50 Years: A Retrospective Survey.

Authors:  Toru Hifumi; Atsushi Sakai; Akihiko Yamamoto; Kazunori Morokuma; Norio Otani; Motohide Takahashi; Manabu Ato
Journal:  Front Public Health       Date:  2022-01-10

5.  Preservation of anti-SARS-CoV-2 neutralising antibodies in convalescent plasma after pathogen reduction with methylene blue and visible light.

Authors:  Luis Larrea; Emma Castro; Laura Navarro; Belén Vera; Clara Francés-Gómez; Beatriz Sánchez-Sendra; Ángel Giménez; Emilia Castelló; Miriam Collado; María-Jesus Vayá; Vicente Mirabet; Virginia Callao; María-Isabel Ortiz-de-Salazar; Roberto Roig; Ron Geller; Cristina Arbona
Journal:  Blood Transfus       Date:  2021-08-02       Impact factor: 5.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.